ARTICLE | Company News
Lexicon grants license to GlaxoSmithKline
August 15, 2001 7:00 AM UTC
GlaxoSmithKline (GSK; LSE:GSK) received a non-exclusive sublicense to LEXG's gene targeting technologies, for use in the pharma company's internal research programs. LEXG will receive an upfront techn...